Mary Bowden

611 total citations
10 papers, 156 citations indexed

About

Mary Bowden is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Mary Bowden has authored 10 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Mary Bowden's work include Prostate Cancer Treatment and Research (4 papers), Nanoparticle-Based Drug Delivery (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Mary Bowden is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Nanoparticle-Based Drug Delivery (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). Mary Bowden collaborates with scholars based in Canada, United Kingdom and United States. Mary Bowden's co-authors include Martin Gleave, Poul H. Sorensen, Thomas J. Podor, Matthew J. Martin, Hon S. Leong, Nataliya Melnyk, Alan So, Hans Adomat, Fan Mo and Cameron J. Koch and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and International Journal of Cancer.

In The Last Decade

Mary Bowden

10 papers receiving 155 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Bowden Canada 7 74 56 33 32 20 10 156
Maria D. Fenor de la Maza United Kingdom 7 53 0.7× 85 1.5× 56 1.7× 32 1.0× 9 0.5× 17 152
Hao Zeng China 8 81 1.1× 42 0.8× 60 1.8× 51 1.6× 7 0.3× 20 206
Şuayib Yalçın Türkiye 7 38 0.5× 25 0.4× 84 2.5× 41 1.3× 14 0.7× 18 160
Sook Kyung South Korea 8 105 1.4× 65 1.2× 104 3.2× 50 1.6× 5 0.3× 29 229
Iason Psilopatis Germany 12 125 1.7× 29 0.5× 51 1.5× 53 1.7× 8 0.4× 42 279
Félicie Sherer Belgium 6 90 1.2× 71 1.3× 54 1.6× 37 1.2× 8 0.4× 7 231
Huili Xu China 7 125 1.7× 35 0.6× 33 1.0× 51 1.6× 13 0.7× 12 226
Elena Kazakova Russia 6 120 1.6× 36 0.6× 67 2.0× 48 1.5× 12 0.6× 9 270
Susan Patalano United States 9 128 1.7× 107 1.9× 40 1.2× 48 1.5× 10 0.5× 13 216

Countries citing papers authored by Mary Bowden

Since Specialization
Citations

This map shows the geographic impact of Mary Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Bowden more than expected).

Fields of papers citing papers by Mary Bowden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Bowden. The network helps show where Mary Bowden may publish in the future.

Co-authorship network of co-authors of Mary Bowden

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Bowden. A scholar is included among the top collaborators of Mary Bowden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Bowden. Mary Bowden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kesch, Claudia, John K. Jackson, Samir Bidnur, et al.. (2020). Design and Characterization of Injectable Poly(Lactic-Co-Glycolic Acid) Pastes for Sustained and Local Drug Release. Pharmaceutical Research. 37(3). 36–36. 11 indexed citations
2.
Kesch, Claudia, Samir Bidnur, Eliana Beraldi, et al.. (2020). A polymeric paste-drug formulation for local treatment of upper tract urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 39(3). 194.e1–194.e7. 5 indexed citations
3.
Kesch, Claudia, Samir Bidnur, Eliana Beraldi, et al.. (2019). A polymeric paste-drug formulation for intratumoral treatment of prostate cancer. Prostate Cancer and Prostatic Diseases. 23(2). 324–332. 4 indexed citations
4.
Li, Yinan, Ruiqi Chen, Mary Bowden, et al.. (2017). Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4. Oncotarget. 8(40). 66878–66888. 19 indexed citations
5.
Cetinbas, Naniye Mallı, Cristina E. Tognon, Gabriel Leprivier, et al.. (2013). Mutation of the Salt Bridge-forming Residues in the ETV6-SAM Domain Interface Blocks ETV6-NTRK3-induced Cellular Transformation. Journal of Biological Chemistry. 288(39). 27940–27950. 11 indexed citations
6.
Nesslinger, Nancy J., Mary Bowden, Paul S. Rennie, et al.. (2009). Castration induces autoantibody and T cell responses that correlate with inferior outcomes in an androgen‐dependent murine tumor model. International Journal of Cancer. 125(12). 2871–2878. 6 indexed citations
7.
Martin, Matthew J., Nataliya Melnyk, Mary Bowden, et al.. (2006). The Insulin-Like Growth Factor I Receptor Is Required for Akt Activation and Suppression of Anoikis in Cells Transformed by the ETV6-NTRK3 Chimeric Tyrosine Kinase. Molecular and Cellular Biology. 26(5). 1754–1769. 57 indexed citations
8.
Skov, Kirsten A., Hans Adomat, Mary Bowden, et al.. (2004). Hypoxia in the Androgen-Dependent Shionogi Model for Prostate Cancer at Three Stages1. Radiation Research. 162(5). 547–553. 17 indexed citations
9.
So, Alan, Mary Bowden, & Martin Gleave. (2004). Effect of time of castration and tumour volume on time to androgen‐independent recurrence in Shionogi tumours. British Journal of Urology. 93(6). 845–850. 8 indexed citations
10.
Morrison, Joe, et al.. (1992). Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Alimentary Pharmacology & Therapeutics. 6(5). 549–555. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026